Sunshine Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.31	9.69	16.29	21.83	2.05	0.99
Short-Term Investments	-	-	-	-	0.01	0.01
Cash & Short-Term Investments	9.31	9.69	16.29	21.83	2.05	1
Cash Growth	-23.76%	-40.55%	-25.36%	963.27%	105.79%	1974.15%
Accounts Receivable	4.16	3.87	2.55	1.91	0.01	0
Receivables	4.16	3.87	2.55	1.91	0.01	0
Inventory	14.06	11.28	5.73	3.29	0.11	0.02
Prepaid Expenses	0.44	1.13	0.31	0.28	0.03	0
Total Current Assets	27.97	25.97	24.89	27.31	2.2	1.03
Property, Plant & Equipment	1.42	1.48	1.01	1.15	0.01	0.02
Other Intangible Assets	2.01	3.02	1.44	0.78	-	-
Long-Term Deferred Tax Assets	0.09	0.09	-	-	-	-
Total Assets	31.49	30.56	27.35	29.24	2.2	1.05
Accounts Payable	6.14	5.54	2.59	2.8	0.04	0.06
Accrued Expenses	-	-	-	-	0.05	0.02
Short-Term Debt	-	-	-	-	-	0.14
Current Portion of Long-Term Debt	-	-	-	-	-	0.82
Current Portion of Leases	0.22	0.21	0.12	0.12	-	-
Current Income Taxes Payable	-	0.27	0.3	0.37	-	-
Other Current Liabilities	0.3	0.3	2.55	3.63	-	-
Total Current Liabilities	6.65	6.31	5.55	6.93	0.09	1.05
Long-Term Debt	-	-	-	-	1.9	0.95
Long-Term Leases	0.64	0.74	0.54	0.64	-	-
Long-Term Deferred Tax Liabilities	-	-	0.05	0.04	-	-
Total Liabilities	7.29	7.06	6.14	7.62	1.99	2
Common Stock	0	0	0	0.02	0	0
Additional Paid-In Capital	97.38	93.35	84.42	80.84	32.79	19.17
Retained Earnings	-72.87	-69.04	-63.91	-59.4	-32.66	-20.22
Comprehensive Income & Other	-0.32	-0.83	0.7	0.16	-0.02	-0
Total Common Equity	24.19	23.49	21.21	21.63	0.11	-1.05
Shareholders' Equity	24.2	23.5	21.21	21.63	0.21	-0.95
Total Liabilities & Equity	31.49	30.56	27.35	29.24	2.2	1.05
Total Debt	0.85	0.95	0.66	0.77	1.9	1.91
Net Cash (Debt)	8.45	8.73	15.63	21.06	0.15	-0.92
Net Cash Growth	-27.45%	-44.14%	-25.77%	13687.37%	-	-
Net Cash Per Share	2.43	12.45	1219.08	-	-	-
Filing Date Shares Outstanding	4.91	2.71	0.05	0.01	-	-
Total Common Shares Outstanding	4.56	2.58	0.01	0.01	-	-
Working Capital	21.32	19.65	19.34	20.38	2.1	-0.03
Book Value Per Share	5.31	9.10	1513.44	1915.04	-	-
Tangible Book Value	22.18	20.47	19.76	20.85	0.11	-1.05
Tangible Book Value Per Share	4.87	7.93	1410.37	1846.25	-	-
Machinery	0.97	0.79	0.54	0.48	-	0.07
Leasehold Improvements	0.09	0.09	0.02	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q